홈 › 삼중음성 유방암 › 미주리 › St. Louis
MO St. Louis의 삼중음성 유방암 임상 시험
삼중음성 유방암 관련 연구 21개가 St. Louis 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Washington University Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
피험자 모집 중1상
- Washington University School of Medicine in St. Louis, St Louis
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
피험자 모집 중1/2상
- Washington University, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
피험자 모집 중관찰 연구
- Washington University, St Louis
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
피험자 모집 중3상
- Siteman Cancer Center ( Site 0099), St Louis
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
피험자 모집 중3상
- Washington University Siteman Cancer Center ( Site 0031), St Louis
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Local Institution - 0140, St Louis
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Washington University, St Louis
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
피험자 모집 중2상
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- 외 1개
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
피험자 모집 중3상
- Washington University School of Medicine, St Louis
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
피험자 모집 중관찰 연구
- Cancer Care Specialist of Illinois, O'Fallon · 16마일 거리
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- Washington University, St Louis
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Research Site, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
피험자 모집 중1상
- Normunity Investigational Site, St Louis
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
피험자 모집 중1상
- Washington University School of Medicine, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
피험자 모집 중관찰 연구
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
A Study of LY4175408 in Participants With Advanced Cancer
피험자 모집 중1상
- Washington University, St Louis
Study of XB010 in Subjects With Solid Tumors
피험자 모집 중1상
- Siteman Cancer Center, St Louis
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
피험자 모집 중1/2상
- Siteman Cancer Center, St Louis
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Washington University, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
피험자 모집 중1/2상
- Washington University, St Louis
다른 도시의 삼중음성 유방암 시험
- Houston, TX연구 42개
- New York City, NY연구 31개
- Nashville, TN연구 28개
- Los Angeles, CA연구 27개
- Boston, MA연구 26개
- San Antonio, TX연구 23개
- Arlington, VA연구 20개
- Atlanta, GA연구 20개
- Dallas, TX연구 18개
- Chicago, IL연구 16개
- Columbus, OH연구 16개
- Grand Rapids, MI연구 15개
St. Louis의 다른 연구
- 비소세포폐암연구 73개
- 유방암연구 64개
- 전이성 암연구 54개
- 대장직장암연구 50개
- 암 (전체)연구 46개
- 전립선암연구 46개
- 폐암연구 39개
- 난소암연구 38개
- 췌장암연구 33개
- 자궁내막암연구 29개
- 두경부 편평세포암연구 28개
- 심부전연구 26개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.